Addex Therapeutics to Ring the Nasdaq Stock Market Closing Bell

Addex Starts Trading American Depositary Shares on Nasdaq Under Ticker ADXN

Addex Provides Trading Update and Completes 2019 with Cash Position of CHF31.5 million

Addex to Attend 38th Annual J.P. Morgan Healthcare Conference

Addex to Receive Additional $800K Funding from Indivior for GABAB PAM Addiction Program

ADDEX THERAPEUTICS PUBLICLY FILES REGISTRATION STATEMENT WITH THE U.S. SEC TO FACILITATE NASDAQ LISTING OF ADSs REPRESENTING SHARES

Addex: Van Leeuwenhoeck Issues Update Equity Research Report

Addex to Attend Jefferies 2019 London Healthcare Conference

Addex to Present at 25th Annual BIO-Europe Conference in Hamburg

Addex to Receive Additional Funding from Indivior for GABAB PAM Addiction Program